Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Intensive Versus Conventional Glycemic Control Targets: An Updated Systematic Review and Meta-Analysis of the 2024 Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Adults.

Critical care medicine·2026
Same author

Authors reply: "Evolution of triglyceride and total cholesterol levels after critical illness: Preliminary insights into post-ICU metabolic sequelae".

Journal of critical care·2026
Same author

Feeding the injured brain: nutrients, dose, timing, and monitoring.

Intensive care medicine·2026
Same author

Nutrition interventions and post-intensive care syndrome: A narrative review.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same author

Evolution of triglyceride and total cholesterol levels after critical illness: Preliminary insights into post-ICU metabolic sequelae.

Journal of critical care·2026
Same author

Exploration of Predictive Factors for Acute Radiotherapy-Induced Gastro-Intestinal Symptoms in Prostate Cancer Patients.

Cancers·2025
Same journal

Capillary refill time changes are associated with Vascular Waterfall response in post-cardiac surgery patients.

Annals of intensive care·2026
Same journal

Age-associated outcomes in cardiogenic shock supported with microaxial flow pumps.

Annals of intensive care·2026
Same journal

Improved survival in patients admitted to ICU with multiple myeloma: a retrospective cohort analysis.

Annals of intensive care·2026
Same journal

Response letter to "Venovenous extracorporeal membrane oxygenation initiation and reduction in vasopressor requirements".

Annals of intensive care·2026
Same journal

Impact of Respiratory Effort Parameters on Clinical Outcomes in Respiratory Failure Patients (Effort-I): A Prospective Observational Study.

Annals of intensive care·2026
Same journal

Human Development Index and outcomes in older critically ill patients: A European multicentre study.

Annals of intensive care·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Statins in the critically ill.

Isabelle De Loecker1, Jean-Charles Preiser

  • 1Department of Intensive Care, Erasme University Hospital, Route de Lennik 808, B-1070, Brussels, Belgium. Jean-Charles.Preiser@erasme.ulb.ac.be.

Annals of Intensive Care
|June 20, 2012
PubMed
Summary
This summary is machine-generated.

Statins may benefit critically ill patients with sepsis or acute lung injury, but more research is needed. Clinicians must carefully consider individual patient needs due to unknown side effects and varied study results.

Related Experiment Videos

Last Updated: May 21, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Area of Science:

  • Critical Care Medicine
  • Pharmacology
  • Intensive Care

Background:

  • Statins are common chronic medications, with emerging evidence suggesting benefits in critical illness.
  • Recent studies indicate potential positive effects of statins in sepsis, acute lung injury/acute respiratory distress syndrome (ALI/ARDS), and after aneurysmal subarachnoid hemorrhage (aSAH).

Purpose of the Study:

  • To review the mechanisms of action of statins.
  • To synthesize current clinical data on statin efficacy and safety in critically ill patients.
  • To provide guidance for intensive care clinicians regarding statin use.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Synthesis of data on statin effects in critical care settings.
  • Analysis of potential benefits and risks of statins in intensive care.

Main Results:

  • Experimental and clinical data suggest beneficial effects of statins in specific critical conditions like sepsis and ALI/ARDS.
  • Current evidence is heterogeneous, with a lack of well-designed prospective studies.
  • The full extent of statin side effects in critically ill patients remains largely unknown.

Conclusions:

  • Definitive conclusions for widespread statin use in intensive care units cannot be drawn yet.
  • Individual patient assessment is crucial for determining potential benefits of statins.
  • Further well-designed prospective studies are required to establish clear guidelines for statin therapy in critical care.